Bristol-Myers Squibb Company (BMY) Gross profit 2011–2020
Bristol-Myers Squibb Company (BMY) annual gross profit history from SEC filings — each fiscal year as reported.
$30.7BFY2020 · since FY2011: $15.6B → $30.7B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2020 | $30.7B | +70.2% |
| FY2019 | $18.1B | +12.3% |
| FY2018 | $16.1B | +9.6% |
| FY2017 | $14.7B | +1.4% |
| FY2016 | $14.5B | +14.5% |
| FY2015 | $12.7B | +5.9% |
| FY2014 | $11.9B | +1.5% |
| FY2013 | $11.8B | -9.6% |
| FY2012 | $13.0B | -16.8% |
| FY2011 | $15.6B | — |
Source: SEC XBRL filings · For reference only · Not investment advice